Why the study?
What is the absolute risk of a first venous thromboembolism during pregnancy and postpartum in women with hereditary thrombophilia?
Population
Pregnant women with hereditary thrombophilia not receiving anticoagulants (36 observational studies included)
Design
Meta-analysis
Follow-up
Pregnancy and postpartum period
Authors
Loading...
Supports targeted VTE prophylaxis for high-risk thrombophilias while avoiding overtreatment in heterozygous carriers.
What is the absolute risk of a first venous thromboembolism during pregnancy and postpartum in women with hereditary thrombophilia?
High-risk thrombophilias (antithrombin, protein C/S deficiency, homozygous factor V Leiden) warrant consideration for VTE prophylaxis during pregnancy/postpartum, whereas heterozygous mutations generally do not.
Croles et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: